The Discounted Cash Flow (DCF) valuation of Zhejiang Starry Pharmaceutical Co Ltd (603520.SS) is 13.12 CNY. With the latest stock price at 10.02 CNY, the upside of Zhejiang Starry Pharmaceutical Co Ltd based on DCF is 30.9%.
Based on the latest price of 10.02 CNY and our DCF valuation, Zhejiang Starry Pharmaceutical Co Ltd (603520.SS) is a buy. buying 603520.SS stocks now will result in a potential gain of 30.9%.
| Range | Selected | |
| WACC / Discount Rate | 8.7% - 10.4% | 9.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 8.84 - 21.79 | 13.12 |
| Upside | -11.8% - 117.4% | 30.9% |